Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 1 Pain 1 Nasopharyngeal Carcinoma 1 Motor Activity 1 Lymphedema 1 Deglutition Disorders 1 Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 17 Iodine-131 16 lenvatinib 13 trametinib 12 Thyrotropin Alfa 11 Sorafenib 11 pembrolizumab 10 dabrafenib 10 Paclitaxel 9 vandetanib 8 Thyroxine 8 Surgical Procedures, Operative 7 Sunitinib 7 selpercatinib 6 cabozantinib 6 Nivolumab 6 Fluorodeoxyglucose F18 6 Everolimus 6 pazopanib 5 Vemurafenib 5 Thyroidectomy 5 Specimen Handling 5 Saline Solution 5 Radiotherapy 5 Radiofrequency Ablation 5 Cyclophosphamide 5 Cisplatin 5 Biopsy 5 apatinib 4 anlotinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Thyroid Neoplasms × Range of Motion, Articular × Clear all

NCT07623005 2026-06-03

PMRT-ThyCa

University of Faisalabad

Phase NA Completed

Pain, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡